A silyl porphyrin derivative conjugated with 6-deoxy-6-sulfo-α-d-glucopyranose functions as an efficient photosensitizer for photodynamic therapy

Photodiagnosis Photodyn Ther. 2024 Feb:45:103898. doi: 10.1016/j.pdpdt.2023.103898. Epub 2023 Nov 24.

Abstract

We synthesized a new silyl porphyrin derivative conjugated with 6-deoxy-6-sulfo-α-d-glucopyranose (SGlc). Conjugation with SGlc improved A549 cellular uptake without significant changes in the photophysical and photochemical properties and subcellular localization. This improved cellular uptake led to enhanced photodynamic activity. Furthermore, conjugation with SGlc suppressed dark toxicity. These advantages were not observed for a conjugate with a glucose molecule. These results indicated that the conjugation with SGlc is a promising strategy for enhancing photodynamic efficacy.

Keywords: 6-deoxy-6-sulfo-α-D-glucopyranose; Photodynamic therapy; Photosensitizer; Silyl porphyrin.

MeSH terms

  • A549 Cells
  • Glucose
  • Humans
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Porphyrins* / pharmacology

Substances

  • Photosensitizing Agents
  • Glucose
  • Porphyrins